CoJourney is reimagining cell and gene therapy CDMO services globally. Based in Zhejiang, China, CoJourney’s platform is built on high purity, high yield, reduced costs, and shorter timelines for the development and manufacture of CGT therapies. They offer cGMP manufacturing and their facilities are compliant under FDA, EMA, and NMPA standards for plasmid, mRNA, and viral vector development. Plasmids are manufactured in a multiproduct cGMP facility that includes multiple upstream suites, downstream suites, and a fill/finish suite with an isolator and filler. The facility includes 30-L disposable fermenters for plasmid production.